Making drug development designable
Nabla (nabla.bio) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 42nd percentile of 9589 Healthcare brands.
Nabla (nabla.bio) is a biotechnology company focused on generative drug design. It combines generative AI-driven computational methods with patient-relevant testing to create drug-like antibodies, aiming to accelerate and de-risk drug development. Nabla positions itself as a partner to pharmaceutical and biotech companies seeking advanced, AI-driven approaches to drug discovery, targeting organizations in the healthcare and technology sectors.
| Brand Name | Nabla |
|---|---|
| Domain | nabla.bio |
| Industry | Healthcare, Technology |
| Main Competitors | Absci (81/100), Generate Biomedicines (73/100), Insilico Medicine (83/100), Recursion Pharmaceuticals (85/100), Isomorphic Labs (79/100), BigHat Biosciences (65/100), Chai Discovery (74/100) |
Moz Domain Authority 29/100 vs category average 41 / leader 97 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Nabla appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Nabla aims to make drug development designable through generative drug design powered by patient-relevant testing." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Nabla's main competitors in Healthcare: Absci (81/100), Generate Biomedicines (73/100), Insilico Medicine (83/100), Recursion Pharmaceuticals (85/100), Isomorphic Labs (79/100).
Sources: Brand Analyzer scan
Nabla has limited AI-search visibility, scoring 33/100 on Brand Analyzer's AI visibility composite (visibility 33, trust 22, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Nabla official site
Nabla scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Nabla official site
Nabla can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Nabla official site
Nabla is a biotechnology company that develops generative computational methods for drug design, combining AI-driven modeling with patient-relevant testing to create drug-like antibodies.
Sources: Nabla official site
Nabla uses generative AI to design drug-like antibodies computationally, integrating patient-relevant testing to validate and refine these designs, with the goal of making drug development faster and less risky.
Sources: Nabla official site
Nabla scores 33/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Nabla has a weak AI-visibility profile at 33/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is trust (22/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 29/100 and thin schema.org structured data.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Nabla: USAging (75/100), Mustimuhw Information Solutions (MIS) (75/100), Namocell (75/100), National Association of School Nurses (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.